The expression levels of estrogen receptors (ER) and progesterone receptors (PR), as well as Her-2 for breast cancer, guide oncologists in predicting prognosis and developing the corresponding therapeutic strategies (9). This evidence concerns the gene ESR1 and breast cancer.